Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.

@article{Marso1999OptimizingTP,
  title={Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.},
  author={Steven P. Marso and Abraham Michael Lincoff and Stephen G. Ellis and Deepak L Bhatt and Jean François Tanguay and Neil Scott Kleiman and Talal Hammoud and Janet E. Booth and Steven Felton Sapp and Eric J. Topol},
  journal={Circulation},
  year={1999},
  volume={100 25},
  pages={
          2477-84
        }
}
BACKGROUND Stenting likely decreases the need for target-vessel revascularization procedures in diabetic patients compared with balloon angioplasty. However, the efficacy of stenting with platelet glycoprotein IIb/IIIa blockade has not yet been assessed in diabetics. METHODS AND RESULTS We analyzed the outcomes of 491 diabetic patients within the multicenter Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial (EPISTENT). Diabetic patients were a prospectively defined subset: 173 were… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 116 CITATIONS, ESTIMATED 67% COVERAGE

Impact of age and hyperglycemia on the mechanical behavior of intact human coronary arteries: an ex vivo intravascular ultrasound study.

  • American journal of physiology. Heart and circulatory physiology
  • 2005
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

1999
2019

CITATION STATISTICS

  • 2 Highly Influenced Citations

References

Publications referenced by this paper.
SHOWING 1-10 OF 23 REFERENCES

Can abciximab prevent neointimal proliferation in PalmazSchatz stents? The final ERASER results

SG Ellis, PW Serruys, +4 authors MB. Effron
  • Circulation
  • 1997